Maximus, Inc. (NYSE:MMS) CEO Richard A. Montoni sold 10,000 shares of the company’s stock in a transaction dated Tuesday, December 5th. The shares were sold at an average price of $69.04, for a total value of $690,400.00. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.
Shares of Maximus, Inc. (NYSE MMS) opened at $70.82 on Friday. Maximus, Inc. has a twelve month low of $51.74 and a twelve month high of $70.83. The company has a market capitalization of $4,568.68, a PE ratio of 22.55, a P/E/G ratio of 2.63 and a beta of 1.35.
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, November 30th. Investors of record on Wednesday, November 15th were issued a $0.045 dividend. The ex-dividend date was Tuesday, November 14th. This represents a $0.18 annualized dividend and a yield of 0.25%. Maximus’s payout ratio is 5.66%.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its holdings in Maximus by 2.4% in the 2nd quarter. Vanguard Group Inc. now owns 5,669,026 shares of the health services provider’s stock worth $355,052,000 after buying an additional 130,839 shares in the last quarter. FMR LLC increased its holdings in Maximus by 10.4% in the 2nd quarter. FMR LLC now owns 4,658,584 shares of the health services provider’s stock worth $291,767,000 after buying an additional 438,025 shares in the last quarter. Victory Capital Management Inc. increased its holdings in Maximus by 13.3% in the 3rd quarter. Victory Capital Management Inc. now owns 3,514,228 shares of the health services provider’s stock worth $226,667,000 after buying an additional 413,325 shares in the last quarter. Janus Henderson Group PLC increased its holdings in Maximus by 718.8% in the 2nd quarter. Janus Henderson Group PLC now owns 2,211,638 shares of the health services provider’s stock worth $138,515,000 after buying an additional 1,941,521 shares in the last quarter. Finally, State Street Corp increased its holdings in Maximus by 3.5% in the 2nd quarter. State Street Corp now owns 2,138,049 shares of the health services provider’s stock worth $133,906,000 after buying an additional 71,823 shares in the last quarter. Institutional investors own 94.82% of the company’s stock.
Several analysts have issued reports on the company. Robert W. Baird assumed coverage on Maximus in a research note on Sunday, September 3rd. They issued a “neutral” rating for the company. Zacks Investment Research lowered Maximus from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th. Finally, Canaccord Genuity dropped their price target on Maximus from $62.00 to $61.00 and set a “hold” rating for the company in a research note on Friday, November 10th. Two investment analysts have rated the stock with a sell rating and six have assigned a hold rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $64.33.
TRADEMARK VIOLATION NOTICE: “Richard A. Montoni Sells 10,000 Shares of Maximus, Inc. (MMS) Stock” was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The correct version of this report can be read at https://www.dispatchtribunal.com/2017/12/09/richard-a-montoni-sells-10000-shares-of-maximus-inc-mms-stock.html.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.